CTRI/2014/01/004354招募中4 期
AN OPEN LABEL, PROSPECTIVE, POST MARKETING STUDY TO EVALUATE THE SAFETY, TOLERABILITY AND EFFICACY OF RITUXIMAB WITH GLUCOCORTICOIDS IN ADULT PATIENTS WITH WEGENERâ??S GRANULOMATOSIS (GRANULOMATOSIS WITH POLYANGIITIS - GPA) OR MICROSCOPIC POLYANGIITIS
试验速览
- 阶段
- 4 期
- 状态
- 招募中
- 入组人数
- 30
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •Male or non-pregnant, non-nursing female,Patients diagnosed with Wegenerâ??s Granulomatosis (Granulomatosis with Polyangiitis - GPA) or Microscopic polyangiitis according to the definitions of the Chapel Hill Consensus Conference,•Patients with either newly diagnosed or relapsing disease, Patients must be positive for either PR3-ANCA or MPO-ANCA at the screening
排除标准
- •Patients with any previous treatment with Rituximab, History of severe allergic or anaphylactic reactions to human, humanized, or murine monoclonal antibodies, Patients with severe heart failure (New York Heart Association Class IV) or severe, uncontrolled cardiac disease,•Patients having active severe infection
研究者
相似试验
尚未招募
4 期
Post Marketing clinical study on surgical wound dressingCTRI/2020/06/026207eosoteria Bandages Pvt Ltd
尚未招募
4 期
Post-marketing observational study to compare the efficacy and safety of ImmulinaTM-800 as add-on therapy against standard of care in the management of patients with Chronic Obstructive Pulmonary Disease.CTRI/2019/07/020005Wockhardt Ltd
已完成
4 期
Post marketing observational study in Allergic rhinitis (group of symptoms affecting the nose) and Urticaria (Hives) patients to know the effectiveness of LevocetirizineCTRI/2022/04/041937Dr Reddys Laboratories110
已完成
4 期
Post Marketing Study of emizibumab in hemophilia A pedicatric patients less than 12 years without FVIII Inhibitors(AOZORA)Hemophilia AJPRN-jRCT1080224629Chugai Pharmaceutical Co., Ltd.30
已完成
不适用
Safety and efficacy of a fixed dose combination of cefepime and amikaciosocomial pneumonia, febrile neutropenia, other bacterial infectionsInfections and InfestationsInfectionsISRCTN61799591Venus Remedies Limited (India)315